© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
8 CMEs You Can Take Today
Our roundup of free CMEs features innovating strategies for diagnosing and addressing the neuropsychiatric signs of multiple sclerosis, the therapeutic potential of psilocybin, poststroke depression, and more.
Our mid-year roundup of free CME articles feature innovating strategies for diagnosing and addressing the neuropsychiatric signs of multiple sclerosis, the therapeutic potential of psilocybin, poststroke depression, and more.
Scroll through the slides for links to the articles.
In addition to having neuropsychiatric symptoms that emerge before more recognizable symptoms of multiple sclerosis (MS), it can impact psychiatric comorbidity and psychiatric illnesses can impact MS prognosis. This CME tracks the complex relationship between MS and various psychiatric disorders and symptomology, and it offers innovative treatment strategies.
https://www.psychiatrictimes.com/view/neuropsychiatric-symptoms-multiple-sclerosis
In addition to having neuropsychiatric symptoms that emerge before more recognizable symptoms of multiple sclerosis (MS), it can impact psychiatric comorbidity and psychiatric illnesses can impact MS prognosis. This CME tracks the complex relationship between MS and various psychiatric disorders and symptomology, and it offers innovative treatment strategies.
https://www.psychiatrictimes.com/view/neuropsychiatric-symptoms-multiple-sclerosis
Psilocybin continues to gain attention for its clinical potential, despite the fact that it is still illegal in many states. This CME explains the science behind psilocybin, its pharmacokinetic profile, and lays out early evidence for its efficacy in treating treatment-resistant depression and neuropsychiatric other conditions.
This CME provides an overview of psychological and cognitive insight, reviews their respective etiologies, distinguishes them from various kinds of pseudo-insight, and explains how to test for and utilize both in clinical practice.
This CME delves into the epidemiology and neurobiology of poststroke depression and teaches clinicians to complete an appropriate assessment and provide comprehensive treatment.
https://www.psychiatrictimes.com/view/different-strokes-spot-treat-poststroke-depression
Epigenetics can potentially contribute to the transgenerational transmission of resilience. In surveying literature on epigenetics and resilience, this CME reviews different treatment modalities that could encourage resilience and improve treatment outcomes.
Autoimmune encephalitis often presents with the symptoms of psychosis, which makes it tempting to prescribe antipsychotics. This CME presents how you can distinguish anti-NMDA receptor encephalitis (ANMDARE) from other conditions, conduct a clinical workup, and then settle on a treatment plan for recurrent ANMDARE episodes.
Fibromyalgia is a difficult condition to diagnose and treat. This CME presents issues in differential diagnosis, including discussions of similar conditions, as well as how to recognize cooccurring mental disorders, and the current recommendations for treatment.
https://www.psychiatrictimes.com/view/fibromyalgia-what-it-is-and-how-to-treat-it